Showing 1 - 5 results of 5 for search 'Stephen John Clarke', query time: 0.03s Refine Results
  1. 1
    Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.

    Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer. by Joseph Chung Yan Chan, Connie Irene Diakos, Alexander Engel, David Lok Hang Chan, Nick Pavlakis, Anthony Gill, Stephen John Clarke

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer

    Correction: Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer by Joseph Chung Yan Chan, Connie Irene Diakos, Alexander Engel, David Lok Hang Chan, Nick Pavlakis, Anthony Gill, Stephen John Clarke

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.

    Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study. by Joseph Chung Yan Chan, Connie Irene Diakos, Alexander Engel, David Lok Hang Chan, Nick Pavlakis, Anthony Gill, Stephen John Clarke

    Published 2019-01-01
    Get full text
    Article
  4. 4
    Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.

    Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer. by Joseph Chung Yan Chan, Connie Irene Diakos, Alexander Engel, David Lok Hang Chan, Nick Pavlakis, Anthony Gill, Stephen John Clarke

    Published 2020-01-01
    Get full text
    Article
  5. 5
    The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

    The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. by Stephen John Clarke, Matthew Burge, Kynan Feeney, Peter Gibbs, Kristian Jones, Gavin Marx, Mark P Molloy, Timothy Price, William H H Reece, Eva Segelov, Niall C Tebbutt

    Published 2020-01-01
    Get full text
    Article

Search Tools: